"Spain and Norway are ready to enrol their patients for COVID-19 clinical trial", announces Dr Tedros Adhanom Ghebreyesu...
Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist in two categories for the Citelin...
Australian CRO Avance Clinical has said that Australia’s fast regulatory approval environment, key opinion leader ...
SGX-listed Singapore eDevelopment Ltd has announced that its wholly-owned U.S. biomedical subsidiary Impact BioMedical, ...
Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced on 11 March 2020 that ...
Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clin...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic...
PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...
Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced th...
Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrou...
CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...
French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of canc...
Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halich...
Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading...
Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people...
NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality ...
Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in a...
